253 related articles for article (PubMed ID: 20591683)
1. Pre-conditioning with the soluble guanylate cyclase activator Cinaciguat reduces ischaemia-reperfusion injury after cardiopulmonary bypass.
Radovits T; Korkmaz S; Miesel-Gröschel C; Seidel B; Stasch JP; Merkely B; Karck M; Szabó G
Eur J Cardiothorac Surg; 2011 Feb; 39(2):248-55. PubMed ID: 20591683
[TBL] [Abstract][Full Text] [Related]
2. Vardenafil protects against myocardial and endothelial injuries after cardiopulmonary bypass.
Szabó G; Radovits T; Veres G; Krieger N; Loganathan S; Sandner P; Karck M
Eur J Cardiothorac Surg; 2009 Oct; 36(4):657-64. PubMed ID: 19523842
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Korkmaz S; Radovits T; Barnucz E; Hirschberg K; Neugebauer P; Loganathan S; Veres G; Páli S; Seidel B; Zöllner S; Karck M; Szabó G
Circulation; 2009 Aug; 120(8):677-86. PubMed ID: 19667237
[TBL] [Abstract][Full Text] [Related]
4. Effects of soluble guanylate cyclase activation on heart transplantation in a rat model.
Loganathan S; Korkmaz-Icöz S; Radovits T; Li S; Mikles B; Barnucz E; Hirschberg K; Karck M; Szabó G
J Heart Lung Transplant; 2015 Oct; 34(10):1346-53. PubMed ID: 26210750
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide- and heme-independent activation of soluble guanylate cyclase attenuates peroxynitrite-induced endothelial dysfunction in rat aorta.
Korkmaz S; Loganathan S; Mikles B; Radovits T; Barnucz E; Hirschberg K; Li S; Hegedüs P; Páli S; Weymann A; Karck M; Szabó G
J Cardiovasc Pharmacol Ther; 2013 Jan; 18(1):70-7. PubMed ID: 22914857
[TBL] [Abstract][Full Text] [Related]
6. Tetrahydrobiopterin improves cardiac and pulmonary function after cardiopulmonary bypass.
Szabó G; Seres L; Soós P; Gorenflo M; Merkely B; Horkay F; Karck M; Radovits T
Eur J Cardiothorac Surg; 2011 Sep; 40(3):695-700. PubMed ID: 21324707
[TBL] [Abstract][Full Text] [Related]
7. Cinaciguat, a novel activator of soluble guanylate cyclase, protects against ischemia/reperfusion injury: role of hydrogen sulfide.
Salloum FN; Das A; Samidurai A; Hoke NN; Chau VQ; Ockaili RA; Stasch JP; Kukreja RC
Am J Physiol Heart Circ Physiol; 2012 Mar; 302(6):H1347-54. PubMed ID: 22268103
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the non-adenosine analogue A1 adenosine receptor agonist (BR-4935) on cardiovascular function after cardiopulmonary bypass.
Veres G; Radovits T; Otila G; Hirschberg K; Haider H; Krieger N; Knoll A; Weigang E; Szabolcs Z; Karck M; Szabó G
Thorac Cardiovasc Surg; 2010 Mar; 58(2):86-92. PubMed ID: 20333570
[TBL] [Abstract][Full Text] [Related]
9. Custodiol-N, the novel cardioplegic solution reduces ischemia/reperfusion injury after cardiopulmonary bypass.
Veres G; Radovits T; Merkely B; Karck M; Szabó G
J Cardiothorac Surg; 2015 Feb; 10():27. PubMed ID: 25890005
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological activation of soluble guanylate cyclase improves vascular graft function.
Veres G; Bai Y; Stark KA; Schmidt H; Radovits T; Loganathan S; Korkmaz-Icöz S; Szabó G
Interact Cardiovasc Thorac Surg; 2021 May; 32(5):803-811. PubMed ID: 33515043
[TBL] [Abstract][Full Text] [Related]
11. Effects of FP15, a peroxynitrite decomposition catalyst on cardiac and pulmonary function after cardiopulmonary bypass.
Radovits T; Beller CJ; Groves JT; Merkely B; Karck M; Szabó C; Szabó G
Eur J Cardiothorac Surg; 2012 Feb; 41(2):391-6. PubMed ID: 21733708
[TBL] [Abstract][Full Text] [Related]
12. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
13. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
14. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
[TBL] [Abstract][Full Text] [Related]
15. Cinaciguat, a soluble guanylate cyclase activator, causes potent and sustained pulmonary vasodilation in the ovine fetus.
Chester M; Tourneux P; Seedorf G; Grover TR; Gien J; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2009 Aug; 297(2):L318-25. PubMed ID: 19465519
[TBL] [Abstract][Full Text] [Related]
16. Cinaciguat, a soluble guanylate cyclase activator, augments cGMP after oxidative stress and causes pulmonary vasodilation in neonatal pulmonary hypertension.
Chester M; Seedorf G; Tourneux P; Gien J; Tseng N; Grover T; Wright J; Stasch JP; Abman SH
Am J Physiol Lung Cell Mol Physiol; 2011 Nov; 301(5):L755-64. PubMed ID: 21856817
[TBL] [Abstract][Full Text] [Related]
17. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
Lapp H; Mitrovic V; Franz N; Heuer H; Buerke M; Wolfertz J; Mueck W; Unger S; Wensing G; Frey R
Circulation; 2009 Jun; 119(21):2781-8. PubMed ID: 19451356
[TBL] [Abstract][Full Text] [Related]
18. Role of soluble guanylate cyclase in renal hemodynamics and autoregulation in the rat.
Dautzenberg M; Kahnert A; Stasch JP; Just A
Am J Physiol Renal Physiol; 2014 Nov; 307(9):F1003-12. PubMed ID: 25209860
[TBL] [Abstract][Full Text] [Related]
19. NO-independent stimulation or activation of soluble guanylyl cyclase during early reperfusion limits infarct size.
Bice JS; Keim Y; Stasch JP; Baxter GF
Cardiovasc Res; 2014 Feb; 101(2):220-8. PubMed ID: 24259501
[TBL] [Abstract][Full Text] [Related]
20. Cardioprotective effects of hydrogen sulfide.
Szabó G; Veres G; Radovits T; Gero D; Módis K; Miesel-Gröschel C; Horkay F; Karck M; Szabó C
Nitric Oxide; 2011 Aug; 25(2):201-10. PubMed ID: 21094267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
